liraglutide + phentermine

Liraglutide + phentermine is a combination of two pharmaceutical agents used off-label for weight management in adults with obesity. Liraglutide is a glucagon-like peptide 1 receptor agonist that enhances glucose-dependent insulin secretion, suppresses glucagon secretion, delays gastric emptying, and reduces appetite. Phentermine is a sympathomimetic amine that acts as an appetite suppressant by stimulating the central nervous system to increase norepinephrine release and reduce hunger signals. The combination has been studied in clinical trials for its potential to augment weight loss beyond what is achieved with either agent alone; however, evidence suggests only modest additional benefit when added to ongoing liraglutide therapy after significant initial weight loss[1][3][4]. Both drugs are approved individually for obesity but not as a fixed-dose combination.

Other names

Saxenda + Adipex-PSaxenda + Lomairaliraglutide-phentermine